Evidence map›Paper›PMID 39132002›Full record

ArticleJournal of the Society for Cardiovascular Angiography & Interventions2024

Rationale and Design of the Latin-American Registry of Peripheral Interventions: Insights From SOLACI Peripheral.

Luis R Virgen-Carrillo, Larry Díaz-Sandoval, Maximiliano Rossi, Gustavo O Pedernera, Ernesto R Duarte, Julio A Pascua, Leslie M Lugo-Gavidia, Pablo Lamelas

Abstract read
In one paragraph

Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luis R Virgen-CarrilloDepartment of Interventional Cardiology, Virgen Cardiovascular Research, Guadalajara, Mexico.
Larry Díaz-SandovalDepartment of Interventional Cardiology, Ascension Borgess Hospital, Kalamazoo, Michigan.
Maximiliano RossiDepartment of Interventional Cardiology, Instituto Cardiovascular Rosario, Santa Fe, Argentina.
Gustavo O PederneraDepartment of Interventional Cardiology, ICBA Instituto Cardiovascular, Buenos Aires, Argentina.
Ernesto R DuarteDepartment of Interventional Cardiology, Hospital Escuela de Agudos Dr Madariaga, Posadas Misiones, Argentina.
Julio A PascuaDepartment of Interventional Cardiology, Hospital Italiano La Plata, Buenos Aires, Argentina.
Leslie M Lugo-GavidiaDobney Hypertension Centre, Medical School, University of Western Australia, Perth, Australia.
Pablo LamelasInstituto de Cardiologia y Cirugia Cardiovascular Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic limb-threatening ischemia (CLTI) represents the most advanced stage of lower extremity peripheral artery disease (PAD). The aim of this manuscript is to provide an overview of the demographic and clinical characteristics of patients with lower-limb peripheral artery disease, as well as the procedural and technical aspects of peripheral endovascular interventions in Latin-America. Methods: The SOLACI peripheral registry is a prospective, multi-center, observational, and hospital-based registry of patients with lower-limb PAD, who are treated with endovascular interventions across Latin American countries. Results: A total of 1057 independent procedures (997 patients) were analyzed in this report. The most common clinical presentation was CLTI (61.2%): Advanced stage of the disease was common, and the symptomatic classification was predominately Rutherford V (minor tissue loss) in 37.6%. Index endovascular procedures mainly treated femoral-popliteal and infrapopliteal regions. Disease extending across multiple vascular territories was common and 27.6% of patients underwent angioplasty of multiple regions during the same procedure. There was a high prevalence of cardiovascular risk factors and concomitant comorbidities: hypertension (84.5%), dyslipidemia 67.4%), diabetes mellitus (64.7%), myocardial infarction (17%) and stroke (8.4%). Major adverse events during hospitalization included death from any cause (1.3%), cardiovascular death (0.7 %), myocardial infarction (0.4%), stroke (0.1%) and bleeding (0.8%). Conclusions: Real-world data on lower limb-PAD in Latin American countries will help us identify unmet needs and generate evidence-based recommendations to facilitate the development of more effective preventive and treatment strategies according to each country's necessities and resources.

Indexed as

endovascularLatin Americalower-limb peripheral artery disease

Identifiers

PMID39132002
PMCPMC11307582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.